Understanding and Healing the Mind: Dr. Karl Deisseroth on Neuroscience, Psychiatry, and Transformative Technologies

This episode features Dr. Karl Deisseroth, a psychiatrist and neuroscientist at Stanford, discussing the intricate landscape of the human mind, its disorders, and the cutting-edge technologies being developed to understand and treat them. Dr. Deisseroth's clinical practice spans a wide range of nervous system disorders, including OCD, autism, schizophrenia, and anxiety. His laboratory has pioneered the development of channelopsins, light-sensitive proteins that enable precise control of neural activity, a technology with the potential to revolutionize psychiatric and neurological treatments by offering more targeted interventions than traditional drugs, as demonstrated by its recent application in restoring light perception to a blind patient. The conversation also touches upon his book, "Projections: A Story of Human Emotions," which uses patient narratives to illuminate brain function in both healthy and diseased states.

A core theme of the discussion is the fundamental distinction between neurology and psychiatry. Psychiatry, unlike neurology, grapples with disorders that lack clear physical biomarkers or objective diagnostic tests, relying instead on subjective patient reports and clinical interpretation. This reliance on "words" makes diagnosis more mysterious and challenging, although efforts are underway to develop quantitative measures like EEG rhythms. Dr. Deisseroth highlights the significant challenge of mental health stigma, which often prevents individuals from seeking timely treatment, potentially leading to worsening conditions like anxiety progressing to depression. He also emphasizes the inherent difficulty in truly understanding one's own or another's internal emotional landscape, underscoring the need for precise language and observation in clinical practice.

The podcast explores the current efficacy and limitations of psychiatric treatments. While therapies like Cognitive Behavioral Therapy for panic disorder, antipsychotic medications for schizophrenia's positive symptoms, and Electroconvulsive Therapy for severe depression can be highly effective, many psychiatric drug discoveries have been serendipitous. Dr. Deisseroth expresses frustration that despite their efficacy, the underlying mechanisms of treatments like ECT remain largely unknown. He draws an analogy to cardiology, where the heart's function as a pump provides a clear framework for understanding and intervention, a level of mechanistic understanding that is still largely missing in psychiatry.

Looking to the future, the conversation delves into the potential for technology to provide objective insights into mental states. While acknowledging privacy concerns, Dr. Deisseroth envisions a future where behavioral metrics (e.g., sleep patterns, activity levels) collected via devices could offer early warning signs of mental health decline, empowering patients with greater agency. Ultimately, the "Bento Box of the perfect cure" for psychiatric illnesses hinges on achieving a deeper, fundamental understanding of brain circuits and their specific functions, moving beyond serendipitous discoveries to design truly effective, precise, and targeted treatments for the complex disorders of the mind.

Psychiatry though, focuses on disorders where we can't see something that's physically wrong, where we don't have a measurable, where there's no blood test that makes the diagnosis, there's no brain scan that tells us this is schizophrenia, and this is depression for an individual patient.

The channelopsins and their related technologies stand to transform the way that we treat psychiatric illness, and various disorders of movement and perception.

I think ultimately there will be quantitative tests... what's going on in the brain in psychiatric disease is physical, and it's due to the circuits and the connections and the projections in the brain that are not working as they would in a typical situation.

I think we're making progress on what the biggest challenge is, which I think there's still such a strong stigma for psychiatric disease that patients often don't come to us, and they feel that they should be able to handle this on their own.

We don't know how other people feel. Most of the time, we don't even really know how we feel.

If someone says, 'Yeah, I can't even think about tomorrow. I don't see how I'm going to get to tomorrow'. That's a nice, precise thing that you know, it's sad, it's tragic, but also, that means something. And we know what that means. That's the hopelessness symptom of depression.

For a motivated, insightful patient, you can have a very cookbooky series of sessions, that's six to 12 sessions, or even less for someone who's very insightful and motivated and it can have a very powerful effect that quickly. And that's just with words.

This is an extraordinarily effective treatment for treatment-resistant depression. At the same time, I find it as heartening as it is to see patients respond to this who have severe depression, I'm also frustrated by it. Why can't we do something more precise than this, for these very severe cases?

Almost every psychiatric treatment has been serendipitously identified, just noting by chance that something that was done for some person also had a side effect-

We don't really have that level of, what is the circuit really there for in psychiatry? And that's what is missing. That's what we need to find, so we can design truly effective and specific treatments.